{"schema_version":"secwatch.filing_event.v1","accession":"0001384101-22-000015","form_type":"8-K","ticker":"VCYT","cik":"0001384101","company_name":"VERACYTE, INC.","filed_at":"2022-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.235184+00:00","generated_at":"2026-06-27T06:00:02.666161+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Veracyte appoints Jonathan Wygant as CAO; Beverly Alley to depart in June 2022","bullets":["Jonathan Wygant named VP & Chief Accounting Officer, effective March 1, 2022.","Wygant receives $350k base salary, 35% bonus target, 24k stock options, 12k RSUs.","Beverly Alley transitions to VP, Accounting through June 30, 2022, then departs.","Alley receives 3 months' salary and COBRA continuation upon separation.","Wygant previously served as corporate controller at Biosplice Therapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001384101-22-000015","json":"https://secwatch.observer/filing/0001384101-22-000015.json","markdown":"https://secwatch.observer/filing/0001384101-22-000015.md","text":"https://secwatch.observer/filing/0001384101-22-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000015/0001384101-22-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000015/vcyt-20220219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T06:00:02.666161+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e9e5ffef0","claim":"Jonathan Wygant was appointed as Vice President and Chief Accounting Officer at VERACYTE, INC..","evidence_excerpt":"On February 22, 2022, Veracyte, Inc. (the “Company”) announced the appointment of Jonathan Wygant, 51, as its Vice President and Chief Accounting Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000015/0001384101-22-000015-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Vice President and Chief Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"1659fbda07","claim":"Beverly Jane Alley was appointed as Vice President, Accounting at VERACYTE, INC..","evidence_excerpt":"In addition, effective February 22, 2022, Beverly Jane Alley, the Company’s Vice President and Chief Accounting Officer, was appointed the Company’s Vice President, Accounting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000015/0001384101-22-000015-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Vice President, Accounting"}],"fact_type":"executive_change"},{"claim_id":"fae53f3ce0","claim":"Beverly Jane Alley departed as Vice President, Accounting at VERACYTE, INC..","evidence_excerpt":"Ms. Alley’s service as Vice President, Accounting would continue through June 30, 2022, at which time, in exchange for a standard release of claims, she would depart from the Company and receive three months’ salary and continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000015/0001384101-22-000015-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"depart"},{"label":"Role","value":"Vice President, Accounting"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}